Remove many-seniors-are-paying-more-for-part-d-medicines-than-their-insurer
article thumbnail

Key Takeaways from New Medicare Law and Its Implications for 340B Stakeholders

Omnicell

This is particularly the case with drug pricing, where advocates have been fighting for more than 30 years over letting Medicare negotiate pharmaceutical prices. So, it came as a big surprise when news broke earlier this month that Senate Majority Leader Chuck Schumer (D-N.Y.) and conservative Democratic Sen. Joe Manchin (W.Va.)